Risk stratification of EGFR+ lung cancer diagnosed with panel-based next-generation sequencing

Objective - Panel-based next-generation sequencing (NGS) is increasingly used for the diagnosis of EGFR-mutated non-small-cell lung cancer (NSCLC) and could improve risk assessment in combination with clinical parameters. - Materials and methods - To this end, we retrospectively analyzed the outcome...

Full description

Saved in:

Bibliographic Details
Main Authors:	Christopoulos, Petros (Author) , Kirchner, Martina (Author) , Bozorgmehr, Farastuk (Author) , Magios, Nikolaus (Author) , Kazdal, Daniel (Author) , Volckmar, Anna-Lena (Author) , Brückner, Lena Marie (Author) , Bochtler, Tilmann (Author) , Kriegsmann, Mark (Author) , Endris, Volker (Author) , Penzel, Roland (Author) , Kriegsmann, Katharina (Author) , Eichhorn, Martin E. (Author) , Herth, Felix (Author) , Heußel, Claus Peter (Author) , El-Shafie, Rami (Author) , Schneider, Marc (Author) , Muley, Thomas (Author) , Meister, Michael (Author) , Schirmacher, Peter (Author) , Bischoff, Helge (Author) , Griesinger, Frank (Author) , Stenzinger, Albrecht (Author) , Thomas, Michael (Author)
Format:	Article (Journal)
Language:	English
Published:	22 August 2020
In:	Lung cancer Year: 2020, Volume: 148, Pages: 105-112
ISSN:	1872-8332
DOI:	10.1016/j.lungcan.2020.08.007
Online Access:	Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1016/j.lungcan.2020.08.007 Verlag, lizenzpflichtig, Volltext: https://www.lungcancerjournal.info/article/S0169-5002(20)30579-1/pdf Resolving-System, Informationsseite zum Volltext: https://doi.org/10.1016/j.lungcan.2020.08.007
Author Notes:	P. Christopoulos, M. Kirchner, J. Roeper, F. Saalfeld, M. Janning, F. Bozorgmehr, N. Magios, D. Kazdal, A.L. Volckmar, L.M. Brückner, T. Bochtler, M. Kriegsmann, V. Endris, R. Penzel, K. Kriegsmann, M. Eichhorn, F.J.F. Herth, C.P. Heussel, R.A. El Shafie, M.A. Schneider, T. Muley, M. Meister, M. Faehling, J.R. Fischer, L. Heukamp, P. Schirmacher, H. Bischoff, M. Wermke, S. Loges, F. Griesinger, A. Stenzinger, M. Thomas

GLASS: Global Lorlatinib for ALK(+) and ROS1(+) retrospective Study$dreal world data of 123 NSCLC patients by Peled, Nir (Author) , Christopoulos, Petros (Author) ,

in: Lung cancer: targets and therapy, 148 (2020), Seite 48-54

Article (Journal) Online Resource

Risk stratification of EGFR+ lung cancer diagnosed with panel-based next-generation sequencing

GLASS: Global Lorlatinib for ALK(+) and ROS1(+) retrospective Study$dreal world data of 123 NSCLC patients by Peled, Nir (Author) , Christopoulos, Petros (Author) ,

Similar Items